Decontamination of Incubators in a NICU (Neonatal Intensive Care Unit)
DECONTA
Evaluation of Two Procedures of Incubator's Decontamination in a NICU
2 other identifiers
observational
40
1 country
1
Brief Summary
Nosocomial infections are responsible for morbidity and mortality in hospitalized neonates. The environment of the neonates and especially the incubators can constitute the reservoir of pathogenic bacteria. That is why decontamination of incubators is a major step in the fight against nosocomial infections in NICUs. The hypothesize is that the usual procedure of decontamination, based on antiseptic molecules, is not sufficient to eradicate all pathogenic bacteria from the incubators. In this study the investigator's aim to assess the efficacy of the usual procedure of decontamination and to compare it with another procedure based on steam pulverization. Another objective will be to explore a possible contamination of the hands of the healthcare workers, that can be involved in the cycle of transmission of bacteria to neonates. Finally, clinical data about the neonates housed in the incubator will be retrieved from clinical reports, to identify the occurrence of sepsis and if so, to compare the bacteria involved in the sepsis and the bacteria present in the incubator.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2020
CompletedFirst Posted
Study publicly available on registry
April 7, 2020
CompletedStudy Start
First participant enrolled
June 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2021
CompletedJuly 26, 2022
July 1, 2022
1.5 years
April 2, 2020
July 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Absence of bacterial contamination
Efficacy of decontamination will be defined for each incubator as the absence of bacterial contamination after the process of decontamination
Day 0 (just before the decontamination)
Absence of bacterial contamination
Efficacy of decontamination will be defined for each incubator as the absence of bacterial contamination after the process of decontamination
Day 0 (just after the decontamination)
Study Arms (2)
standard decontamination
incubators decontaminated with antiseptic molecules, healthcare workers involved in this decontamination, patients housed in these incubators
steam pulverization
incubators decontaminated with steam pulverization, healthcare workers involved in this decontamination, patients housed in these incubators
Interventions
Each incubator will be sampled in 5 points before and after decontamination. The healthcare worker that will be involved in the decontamination will also be sampled (skin sample of the hand) before and after decontamination of the incubator. All the samples will be analyzed for the presence of pathogenic bacteria, using an inoculation on selective agar then an identification of each bacterial colony.
Eligibility Criteria
Healthcare workers of the NICU of the Hopital Femme Mere enfant (HFME), Hospices Civils de Lyon, that will be involved in the process of decontamination of the incubators during the study period.
You may qualify if:
- Healthcare workers involved in the decontamination process of incubators during the study period (period of sampling of incubators before and after decontamination)
- The two people involved in the sampling of incubators
- The patients (neonates) that will be housed in one incubator decontaminated and sampled during the study period
You may not qualify if:
- Refusal to participate for healthcare workers and people involved in the sampling
- Refusal to give access to the clinical data of his child for the parent of the patients included in the study-
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Femme Mère Enfant
Bron, 69500, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2020
First Posted
April 7, 2020
Study Start
June 8, 2020
Primary Completion
December 20, 2021
Study Completion
December 20, 2021
Last Updated
July 26, 2022
Record last verified: 2022-07